Senior Data Science Consultant, Insurance - Remote CSAA Insurance GroupSenior Data Science Consultant, Insurance - RemoteRichmond, VARemote$160,155–$177,950 / yearAlabama - Home Teleworkers, Alabama - Home Teleworkers, Arkansas - Home Teleworkers, California - Home Teleworkers, Colorado - Home Teleworkers, Connecticut - Home Teleworkers, Delaware - Home Teleworker, District of Columbia - Home Teleworkers, Florida - Home Teleworkers, Georgia - Home Teleworkers, Idaho - Home Teleworkers, Illinois - Home Teleworkers, Indiana - Home Teleworkers, Iowa - Home Teleworkers, Kansas - Home Teleworker, Kentucky - Home Teleworkers, Louisiana - Home Teleworkers, Maine Home Teleworkers, Maryland - Home Teleworkers, Massachusetts - Home Teleworkers, Michigan - Home Teleworkers, Minnesota - Home Teleworkers, Mississippi - Home Teleworker, Missouri - Home Teleworker, Montana - Home Teleworkers {+ 21 more}. You will work closely with senior leaders and cross-functional teams to design simulation frameworks, interpret results, communicate assumptions and limitations, and influence decisions that may shape CSAA's long-term strategy.
Hybrid Remote Bcba CSD Autism ServicesHybrid Remote BcbaRichmond, VARemote$90,000–$100,000 / yearAs a fast-growing leader in the field, we're known for our vibrant culture, hands-on training, and career pathways that help you grow just as much as those we serve. Board Certified Behavior Analyst (BCBA) ready to join and lead breakthrough and innovative ABA program focused on clinical quality and client experience.
Medical Science Liaison II, Screening Guardant Health IncMedical Science Liaison II, ScreeningRichmond, VARemote$164,900–$226,750 / yearPrimary Location: Remote-USA-NY Primary Location Base Pay Range: $164,900 - $226,750 Other US Location(s) Base Pay Range: $164,900 - $226,750 If the role is performed in Colorado, the pay range for this job is: $164,900 - $226,750. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.